Gender Difference in 2-Year Mortality and Immunological Response to ART in an HIV-Infected Chinese Population, 2006–2008

Open Access

Peer-reviewed

Research Article

Zhihui Dou,

Affiliation National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
⨯
Jiahong Xu,

Affiliation Westat Inc., Rockville, Maryland, United States of America
⨯
Jin Hua Jiao,

Affiliation Westat Inc., Rockville, Maryland, United States of America
⨯
Ye Ma,

Affiliation National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
⨯
Stephen Durako,

Affiliation Westat Inc., Rockville, Maryland, United States of America
⨯
Lan Yu,

Affiliation National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
⨯
Yan Zhao,

Affiliation National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
⨯
Fujie Zhang

* E-mail: treatment@chinaaids.cn

Affiliation National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
⨯

Reader Comments (0)

Antiretroviral therapy
Is the Subject Area "Antiretroviral therapy" applicable to this article?

Thanks for your feedback.
Immune response
Is the Subject Area "Immune response" applicable to this article?

Thanks for your feedback.
Death rates
Is the Subject Area "Death rates" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
China
Is the Subject Area "China" applicable to this article?

Thanks for your feedback.
Hemoglobin
Is the Subject Area "Hemoglobin" applicable to this article?

Thanks for your feedback.
Signs and symptoms
Is the Subject Area "Signs and symptoms" applicable to this article?

Thanks for your feedback.
Viral load
Is the Subject Area "Viral load" applicable to this article?

Thanks for your feedback.